The Ottawa score for prediction of recurrent venous thromboembolism in cancer patients treated with tinzaparin: an individual patient data meta-analysis
Céline Chapelle(Inserm), Silvy Laporte(Inserm), Luis Jara‐Palomares(Instituto de Salud Carlos III), Isabelle Mahé(Inserm), Patrick Mismetti(Saint-Gobain (France)), Géraldine Poénou(Inserm), Olivier Sanchez(Inserm), Guy Meyer(Onze Lieve Vrouwziekenhuis Hospital), Philippe Girard(Institute Mutualiste Montsouris)
Cited by 1
Related Papers
The 2019 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism
|European Heart Journal|2019|331
Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases
|European Respiratory Journal|2018|214
Can CT Replace Bronchoscopy in the Detection of the Site and Cause of Bleeding in Patients with Large or Massive Hemoptysis?
|American Journal of Roentgenology|2002|176
Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail Inpatients
|Clinical Pharmacology & Therapeutics|2009|126
Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery
|New England Journal of Medicine|2020|96